S-fluoxetine in the prophylaxis of migraine: A phase II double-blind randomized placebo-controlled study

Cephalalgia

Volumn 18, Issue 5, 1998, Pages 283-286

  Steiner, T J ^a   Ahmed, F ^a   Findley, L J ^b   MacGregor, E A ^c   Wilkinson, M ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b OLDCHURCH HOSPITAL   (United Kingdom)

^c City of London Migraine Clinic   (United Kingdom)

Author keywords

Enantiomer; Fluoxetine; Migraine; Placebo; Randomized controlled trial

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ENANTIOMER; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PHASE 2 CLINICAL TRIAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; TREATMENT OUTCOME;

EID: 0031878157     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1998.1805283.x     Document Type: Article

References (14)

1. Goadsby PJ. How do the currently used prophylactic agents work in migraine? Cephalalgia 1997;17:85-92
2. Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache 1992;32:101-4
3. Editorial. Selective serotonin reuptake inhibitors for depression? Drug Therap Bull 1993;31:57-8
4. Montgomery SA. The benefits and risks of 5-HT uptake inhibitors in depression. Br J Psychiatry 1988;153 Suppl 3: 7-10
5. Lance JW, Lambert GA, Goadsby PJ, Zagami AS. 5-hydroxytryptamine and its putative aetiological involvement in migraine. Cephalalgia 1989;9 Suppl 9:7-13
6. Saper JR, Silberstein SD, Lake AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994;34:497-502
7. Wong DT, Fuller RW, Robertson DW. Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. Acta Pharm Nord 1990;2:171-80
8. 2c receptor. Psychopharmacology 1996;126:234-40
9. Wong DT, Bymaster FP, Reid LR, Fuller RW, Perry KW. Inhibition of serotonin uptake by optical isomers of fluoxetine. Drug Develop Res 1985;6:397-403
10. 1A receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol Biochem Behav 1996;54:143-7
11. Bergstrom RF, Lemberger L, Farid NA, Wolen RL. Clinical pharmacology and pharmacokinetics of fluoxetine: a review. Br J Psychiatry 1988;153 Suppl 3:47-50
12. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:9-90
13. International Headache Society Committee on Clinical Trials in Migraine. Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia 1991;11:1-12
14. Wong DT, Bymaster FP, Reid LR, Mayle DA, Krushinski JH, Robertson DW. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacology 1993;8:337-44